Publication:
How to stem the tide? Development of three scoping reviews in biomarkers and personalized prevention

dc.contributor.authorPlans-Beriso, Elena
dc.contributor.authorBabb-de-Villiers, Chantal
dc.contributor.authorPetrova, D
dc.contributor.authorGarcía-Ovejero, Ester
dc.contributor.authorCraciun, Oana Marilena
dc.contributor.authorFernández Martínez N
dc.contributor.authorTurner, H
dc.contributor.authorBarahona-López, Cristina
dc.contributor.authorDiez, P
dc.contributor.authorHernández, Orlando
dc.contributor.funderUK Research and Innovation
dc.contributor.funderUnión Europea. Comisión Europea. Horizonte Europa
dc.date.accessioned2024-06-07T13:25:33Z
dc.date.available2024-06-07T13:25:33Z
dc.date.issued2023
dc.descriptionXLI Reunión anual de la Sociedad Española de Epidemiología (SEE) y XVIII Congresso da Associação Portuguesa de Epidemiología (APE). Porto (Portugal), del 5 al 8 de septiembre de 2023.es_ES
dc.description.abstractThe “PeRsOnalized Prevention roadmap for the future HEalThcare” (PROPHET) project, seeks to assess the effectiveness, clinical utility and existing gaps in current personalized preventive approaches, and to develop a Strategy Research and Innovation Agenda (SRIA) for the European Union. The first draft of the SRIA concept paper needs to incorporate the state of the art of personalized prevention carried out through scoping reviews. Among them, our work aimed to answer whether there is any biomarker or combination of biomarkers that can help to better identify subgroups of individuals with different risks of developing a particular disease for primary or secondary prevention. These results were needed at early stage of the project; despite covering such a broad topic, it had to be carried out in record time (4 months) by a geographically dispersed team (Granada, Madrid, United Kingdom). Our challenge has been to maintain effective coordination and speed without losing scientific rigor. Between Feb-June 2023, our team conducted three independent scoping reviews (for cardiovascular diseases, neurodegenerative diseases and cancer, respectively) that involved quick and difficult decisions to narrow down the inclusion criteria, study populations, biomarkers included, and types of prevention. To maintain consistency, we created different glossaries and had multiple meetings and constant contact between team members. As a first step, we identified key terms on the topics of interest, helped by expert consultations, identification of significant publications and several specific tools (SR-Accelerator, etc.). A pilot study was conducted to refine the search matrix and to initiate coordination among reviewers. However, in order to shorten timeframes, we limited peer review to 10% of the records in all phases. The protocol, published in OSF, served as a guide for the report. All phases, when possible, overlapped to deliver the report on time. In addition, we made interactive evidence maps to show the results graphically, thanks to the creation of a script, using R and Python, to allow the input of the datasheet extraction file into the mapping application. Despite these challenges, we successfully met the project deadlines.es_ES
dc.description.peerreviewedNoes_ES
dc.description.sponsorshipFunding: HE No 10105772. UKRI No 10040946.es_ES
dc.format.numberS1es_ES
dc.format.page205-205es_ES
dc.format.volume37es_ES
dc.identifier.citationGac Sanit. 2023;37(S1):205-205.es_ES
dc.identifier.journalGac Sanit.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/19717
dc.language.isoenges_ES
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/10105772es_ES
dc.relation.publisherversionhttps://www.gacetasanitaria.org/es-vol-37-num-s1-sumario-S0213911123X00028?local=truees_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCanceres_ES
dc.subjectBiomarkeres_ES
dc.subjectCardiovascular Diseaseses_ES
dc.subjectNeurodegenerative Diseaseses_ES
dc.subjectChronic Diseaseses_ES
dc.subjectStudy populationes_ES
dc.subjectLifestylees_ES
dc.subjectRisk factorses_ES
dc.subjectPROPHET projectes_ES
dc.subjectScoping reviewes_ES
dc.subjectPersonalized preventiones_ES
dc.titleHow to stem the tide? Development of three scoping reviews in biomarkers and personalized preventiones_ES
dc.typeconference proceedingses_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationa2e2dc65-eb66-40fc-8ba9-e95f3742016d
relation.isAuthorOfPublication82b7c074-8273-4f0e-91af-450525d5206f
relation.isAuthorOfPublication6b461267-8585-480d-9852-4ef0a2367315
relation.isAuthorOfPublication.latestForDiscoverya2e2dc65-eb66-40fc-8ba9-e95f3742016d
relation.isFunderOfPublication69c5c2cf-27f2-4969-bdc7-1fd0320137eb
relation.isFunderOfPublication00cde69c-0ce1-44c4-ab2f-221edcf8dcca
relation.isFunderOfPublication.latestForDiscovery69c5c2cf-27f2-4969-bdc7-1fd0320137eb
relation.isPublisherOfPublication7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isPublisherOfPublication.latestForDiscovery7d471502-7bd5-4f7a-90a4-8274382509ef

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
HowStemTide_2023.pdf
Size:
391.73 KB
Format:
Adobe Portable Document Format
Description: